Centene Board Got No Red Flags On Pricing, Del. Court Told
A stockholder suit accusing Centene Corp. directors of failing to curtail Medicaid fraud fails to show a majority of the board knew about the company's alleged pricing problem or that they...To view the full article, register now.
Already a subscriber? Click here to view full article